Cibus’ (CBUS) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Cibus (NASDAQ:CBUS) in a research report report published on Friday,Benzinga reports. The brokerage currently has a $25.00 price objective on the stock. HC Wainwright also issued estimates for Cibus’ Q1 2025 earnings at ($0.66) EPS, Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Separately, Canaccord Genuity Group dropped their price target on Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd.

Cibus Stock Down 6.4 %

Shares of NASDAQ CBUS opened at $2.05 on Friday. Cibus has a 12 month low of $1.80 and a 12 month high of $23.18. The company has a market cap of $54.23 million, a price-to-earnings ratio of -0.09 and a beta of 2.04. The business has a fifty day simple moving average of $2.33 and a 200-day simple moving average of $3.31.

Cibus (NASDAQ:CBUS) last announced its earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. The company had revenue of $1.21 million for the quarter, compared to analysts’ expectations of $1.13 million. As a group, sell-side analysts expect that Cibus will post -2.96 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Two Sigma Investments LP acquired a new position in Cibus during the fourth quarter valued at $68,000. Nuveen Asset Management LLC raised its stake in shares of Cibus by 87.7% during the 4th quarter. Nuveen Asset Management LLC now owns 37,978 shares of the company’s stock worth $106,000 after purchasing an additional 17,744 shares in the last quarter. Granby Capital Management LLC raised its stake in shares of Cibus by 300.0% during the 4th quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock worth $556,000 after purchasing an additional 150,000 shares in the last quarter. Deutsche Bank AG raised its stake in shares of Cibus by 418.2% during the 4th quarter. Deutsche Bank AG now owns 45,841 shares of the company’s stock worth $127,000 after purchasing an additional 36,995 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in shares of Cibus by 113.4% during the 4th quarter. Bank of America Corp DE now owns 35,536 shares of the company’s stock worth $99,000 after purchasing an additional 18,885 shares in the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.